ArticleMolecular cancer research : MCR2017

Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.

Michelle M Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.